Net Income

For the third straight year, WesBanco is named a top regional bank by Newsweek, a nod to its financial health, deep community roots, and customer trust.

Following a reverse stock split and rebrand, Golf Entertainment Group (GLFE) uplists to the OTCQB exchange, signaling a strategic push for new capital.

After a multi-year slump, investors poured nearly $14 billion into cybersecurity in 2025, driven by AI risks and the relentless growth of cybercrime.

Bank7 Corp. is set to reveal its 2025 results. With a strong track record and new acquisitions, will it beat expectations amid a mixed regional economy?

Peachtree Group's new division closes nearly $30M in its first quarter, capitalizing on a growing credit gap in middle-market equipment finance.

Lifepoint Health partners with iScribeHealth, deploying ambient AI scribes across its network to reduce documentation and improve patient care.

A biotech firm's promising concussion therapy, backed by NFL's Alex Smith, shows an 85% responder rate and now seeks public funding for its final push.

The 2026 auto show reveals a market in flux. Hybrids are back, EVs adapt post-rebate, and the hunt for affordable cars intensifies. What's next?

The global asset manager appoints Kikuo Shirose to lead its Japan office, signaling a deep push into the nation's booming real assets and alternatives market.

Marqeta completes its executive leadership refresh, appointing a seasoned fintech and payments expert to drive its next phase of profitable growth.

Teal Health's FDA-authorized Teal Wand is now available in all 50 states, aiming to revolutionize preventive care for millions of overdue women.

Blockchain firm BTCS reports 290% revenue growth, pioneering a new model that blends DeFi with public markets to build an Ethereum powerhouse.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.

A new global study shows consumers embrace AI for product research but don't trust it for purchases, revealing a 'Confidence Economy' ruled by transparency.

Blackstone is now the sole institutional backer of AIR Control Concepts, fueling the HVAC leader's rapid growth and strategic expansion into the booming data center market.

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.

Fresh off its 'Fierce 15' win, Recludix Pharma and its billion-dollar Sanofi pact take the spotlight with a novel oral drug for inflammatory diseases.

Backed by the LEGO family's firm, Adapture Renewables secures major U.S. Bank financing to build out its 441 MW Titanium solar portfolio in IL and AR.